Robert G Finizio's Net Worth
$56 Million
Who is Robert G Finizio?
Robert G Finizio has an estimated net worth of $56 Million. This is based on reported shares across multiple companies, which include TherapeuticsMD, Inc., and ZyVersa Therapeutics, Inc..
SEC CIK
Robert G Finizio's CIK is 0001532235
Past Insider Trading and Trends
2018 was Robert G Finizio's most active year for acquiring shares with 17 total transactions. Robert G Finizio's most active month to acquire stocks was the month of November. 2018 was Robert G Finizio's most active year for disposing of shares, totalling 33 transactions. Robert G Finizio's most active month to dispose stocks was the month of November. 2019 saw Robert G Finizio paying a total of $449,018.80 for 159,406 shares, this is the most they've acquired in one year. In 2014 Robert G Finizio cashed out on 1,082,053 shares for a total of $7,170,822.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.33
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +0.51% | 90.64K |
$1.04 | -$70,404.88 | 17.99M |
May 10 - May 11
| |||
Form 4
| -2.72% | -500.96K |
$0.85 | $0.16 | 17.9M |
Feb 28 - Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
| +0.25% | 46K |
$1.44 | $66,360.00 | 18.4M |
Jun 9
| |||
Form 4
| +0.16% | 30K |
$1.15 | $34,600.00 | 18.36M |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +0.39% | 72K |
$2.75 | $198,000.00 | 18.33M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
| +0.19% | 35K |
$2.74 | $95,900.00 | 18.25M |
Aug 20
| |||
Form 4
| -0.80% | -147.59K |
$2.96 | $155,118.80 | 18.22M |
Feb 28 - Aug 9
| |||
Form 4
|
—
|
0
|
$1.88 | -$658,283.82 | 18.37M |
Scheduled
|
Dec 19 - Dec 20
| ||
Form 4
| -0.15% | -27.00K |
$2.34 | -$825,460.80 | 18.37M |
Scheduled
|
Dec 6 - Dec 7
| ||
Form 4
|
—
|
0
|
$2.47 | -$870,356.80 | 18.39M |
Scheduled
|
Nov 26 - Nov 27
| ||
Form 4
|
—
|
0
|
$2.43 | -$858,856.80 | 18.39M |
Scheduled
|
Nov 12 - Nov 13
| ||
Form 4
|
—
|
0
|
$2.69 | -$953,340.80 | 18.39M |
Scheduled
|
Oct 25 - Oct 26
| ||
Form 4
|
—
|
0
|
$2.83 | -$1,002,100.80 | 18.39M |
Scheduled
|
Oct 11 - Oct 12
| ||
Form 4
|
—
|
0
|
$3.37 | -$1,200,268.80 | 18.39M |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
|
—
|
0
|
$3.17 | -$1,128,508.80 | 18.39M |
Scheduled
|
Sep 6 - Sep 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +0.15% | 31.53K |
$3.00 | $94,578.00 | 21.06M |
May 9
| |||
Form 4
| -4.46% | -982.05K |
$6.70 | -$6,576,907.15 | 21.03M |
Mar 26
| |||
Form 4
| -0.23% | -50.00K |
$6.17 | -$308,686.03 | 22.01M |
Scheduled
|
Feb 19 - Feb 21
| ||
Form 4
| -0.23% | -50.00K |
$5.70 | -$285,229.74 | 22.06M |
Scheduled
|
Jan 21 - Jan 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16 - Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZyVersa Therapeutics, Inc. (ZVSA) Snapshot price: $0.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||